Patent details

Basic Information

Publication number:

EP3222275

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171548589

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS

French Title of Invention:

PROCÉDÉS DE SURVEILLANCE THÉRAPEUTIQUE DE PROMÉDICAMENTS À BASE D'ACIDE PHÉNYLACÉTIQUE

German Title of Invention:

VERFAHREN ZUR THERAPEUTISCHEN ÜBERWACHUNG VON PHENYLESSIGSÄURE-PRODRUGS

SPC Number:

Dates

Filing date:

11/09/2012

Grant date:

24/06/2020

EP Publication Date:

27/09/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/06/2020

EP B1 Publication Date:

24/06/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/09/2020

Expiration date:

11/09/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/06/2020

 

 

Name:

Immedica Pharma AB

Address:

Norrtullsgatan 15, 113 29 Stockholm, Sweden (SE)

Inventor

1

Name:

MOKHTARANI, Masoud

Address:

United States (US)

2

Name:

SCHARSCHMIDT, Bruce

Address:

United States (US)

Priority

Priority Number:

201261636256 P

Priority Date:

20/04/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/185; A61K 31/192; A61K 31/216; A61P 1/16; A61P 13/12; A61P 43/00; G01N 33/68;

Publication

European Patent Bulletin

Issue number:

202026

Publication date:

24/06/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages